Unichem Laboratories Limited

Web: unichemlabs.com NSE: UNICHEMLAB BSE: 506690 SECTOR: Healthcare - Pharmaceuticals & Biotechnology | Add Note | View Notes

553 5(1%)

Volume

1L as on 23, Jun

Open

715

High

728

Low

705

548

VWAP

442

52 Week High

687

52 Week Low

278

Viand Research Rating

Quality Score

19/100

Growth Score

35/100

Valuation Score

50/100

Momentum Score

45/100

Analyst Recommendations

BUY/SELL

Hold | Buy | Strong Buy

Analyst Price Target

Market Cap (cr)

3,896

No. of Shares

7.04

P/E

304.18

P/B

2.54

Face Value

Div. Yield

Book Value (TTM)

CASH

DEBT

EPS (TTM)

ROE

0.84

ROCE

Profit Growth

Listing Date

07-Feb-01

Promoter Holding

70.22%

FII Holding

DII Holding

10.63%

Price Chart

Price Performance

1 Week2%

1 Month18%

3 Months45%

6 Months34%

1 Year34%

YTD34%

Moving Average

5 Day SMA445

10 Day SMA446

20 Day SMA404

30 Day SMA392

50 Day SMA382

61 Day SMA368

80 Day SMA0

200 Day SMA0

PIVOT LEVEL

	Standard	Camarilla	Fibonacci	Woodie's
Resistance 3	466	451	461	465
Resistance 2	461	450	456	460
Resistance 1	454	449	453	454
Pivot Point	449	448	449	449
Support 1	443	447	445	442
Support 2	438	446	442	437
Support 3	431	445	438	431

Competitors/Peers

#	Symbol	MCAP	LTP	1W	1M	6M	1Y	P/E	Ind PE	Debt/Eq	NP Qtr Rs.Cr.
1	SUNPHARMA	4,56,655	1899	0%	2%	9%	21%	37	57.7	0.07	11509
2	DIVISLAB	2,43,196	9161	2%	8%	44%	51%	69	57.7	0	2568
3	TORNTPHARM	1,84,303	4846	2%	3%	12%	36%	72	57.7	1.79	2138
4	APOLLOHOSP	1,24,834	8650	1%	1%	12%	10%	58	57.7	0.9	2003
5	ZYDUSLIFE	1,12,897	1132	4%	2%	26%	13%	20	57.7	0.46	5124
6	CIPLA	1,11,346	1385	2%	5%	3%	12%	22	57.7	0.02	3862
7	LAURUSLABS	99,634	1844	3%	3%	75%	114%	0	57.7	0.48	890
8	DRREDDY	96,962	1151	2%	2%	11%	8%	20	57.7	0.2	4158
9	MAXHEALTH	96,646	985	1%	10%	8%	14%	0	57.7	0.32	1442
10	LUPIN	96,620	2113	1%	11%	8%	10%	23	57.7	0.29	5355
Load More

Shareholding Pattern (%)

	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021
Promoters	(0.01) 70.22%	(0.01) 70.22%	(0.01) 70.22%	(0.01) 70.22%	(0.01) 70.22%	(0.01) 70.22%	(0.01) 70.22%	(0.01) 70.22%	(0.01) 70.22%	(0.01) 70.22%	(19.31) 70.21%	(0.01) 50.94%	(0.01) 50.94%	(0.01) 50.94%	(0.01) 50.94%	(0.01) 50.93%	(0.01) 50.93%	(0.01) 50.93%	(0.01) 50.93%
FIIs	(0.01) 1.00%	(0.01) 0.99%	(0.01) 0.99%	(0.01) 0.98%	(-0.11) 0.98%	(0.11) 1.05%	(0.01) 0.94%	(0.01) 0.89%	(0.11) 0.90%	(0.01) 0.84%	(-0.81) 0.83%	(-0.11) 1.62%	(0.11) 1.70%	(-0.21) 1.56%	(0.21) 1.71%	(0.01) 1.50%	(0.01) 1.47%	(-0.11) 1.45%	(0.01) 1.53%
DIIs	(-0.11) 10.63%	(0.01) 10.73%	(-0.21) 10.74%	(-0.41) 10.92%	(-0.31) 11.32%	(0.01) 11.63%	(0.11) 11.65%	(0.31) 11.57%	(0.81) 11.26%	(0.51) 10.46%	(0.41) 10.00%	(1.51) 9.65%	(-0.11) 8.15%	(-0.51) 8.21%	(-0.81) 8.70%	(-0.11) 9.53%	(0.31) 9.59%	(0.21) 9.30%	(0.01) 9.09%
Public	18.14%	18.05%	18.04%	17.88%	17.47%	17.11%	17.17%	17.32%	17.63%	18.47%	18.95%	37.80%	39.21%	39.31%	38.67%	38.04%	38.01%	38.32%	38.44%
No. of Shareholders	23,386	23,267	23,577	23,010	21,621	21,472	20,374	20,621	21,171	20,877	21,584	26,642	29,418	30,618	29,573	32,666	33,557	35,313	33,892

Quarterly Results

	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021	Jun 2021
Sales	575	521	579	527	587	533	507	483	432	466	416	423	402	302	329	310	370	311	291	297.91
Sales Growth % (YoY)	-2%	-2.2%	14.1%	9%	36%	14.5%	22.1%	14.2%	7.4%	54%	26.4%	36.7%	8.7%	-2.8%	13.1%	3.9%	35%	-4.6%	-8.5%	-6.1%
Sales Growth % (QoQ)	10.4%	-10%	9.9%	-10.2%	10.1%	5.1%	5%	11.8%	-7.3%	12%	-1.7%	5.2%	33.1%	-8.2%	6.1%	-16.2%	19%	6.9%	-2.3%	-
Expenses	527	476	513	504	503	448	452	443	406	435	407	395	386	345	347	311	302	313	284	299.63
Operating Profit	48	45	66	22	84	86	55	40	25	31	9	28	16	-43	-18	-1	68	-1	6	-1.72
OPM %	8	9	11	4	14	16	11	8	6	7	2	7	4	-14	-6	0	18	0	2	-0.58
Other Income	11	287	-37	7	9	14	9	4	-119	79	6	9	-28	16	4	8	14	15	3	15.81
Interest	9	7	8	7	5	7	5	4	5	6	7	6	6	4	5	3	2	1	2	1.01
Depreciation	31	31	31	32	30	31	32	32	27	32	29	29	30	31	28	25	23	23	22	22.12
Profit before tax	19	293	-11	-9	58	62	27	8	-126	73	-22	2	-47	-61	-47	-21	58	-11	-16	-9.04
Tax %	42	10	10	16	8	6	9	74	3	0	12	132	-6	4	50	13	-23	24	-17	27.1
Net Profit	11	264	-12	-10	53	58	25	2	-129	73	-24	-1	-44	-64	-71	-23	71	-14	-13	-11.49
Net Profit Growth % (QoQ)	-95.8%	2300%	-20%	-118.9%	-8.6%	132%	1150%	101.6%	-276.7%	404.2%	-2300%	97.7%	31.2%	9.9%	-208.7%	-132.4%	607.1%	-7.7%	-13.1%	-
Net Profit Growth % (YoY)	-79.2%	355.2%	-148%	-600%	141.1%	-20.5%	204.2%	300%	-193.2%	214.1%	66.2%	95.7%	-162%	-357.1%	-446.2%	-100.2%	-	-	-	-
TTM Net Profit	253	295	89	126	138	-44	-29	-78	-81	4	-133	-180	-202	-87	-37	21	32.51	-38.49	-24.49	0
EPS in Rs	1.55	37.54	-1.69	-1.49	7.52	8.22	3.5	0.29	-18.37	10.4	-3.48	-0.1	-6.29	-9.08	-10.04	-3.32	10.15	-2	-1.82	-1.63

Profit and Loss

	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013
Sales	2202	2111	1785	1343	1270	1235	1104	1180	815	698	1333	1202	1133	1081
Sales Growth %	4.3%	18.2%	32.9%	5.8%	2.8%	11.9%	-6.5%	44.9%	16.8%	-47.6%	10.9%	6%	4.9%	23.5%
Expenses	2018	1846	1698	1389	1198	1144	1153	1254	942	738	1169	1100	956	906
Operating Profit	184	265	87	-46	72	91	-49	-74	-128	-41	164	101	178	174
OPM %	8	13	5	-3	6	7	-4	-6	-16	-6	12	8	16	16
Other Income	265	35	-26	0	47	50	91	91	2735	184	15	20	83	13
Interest	32	21	23	17	6	5	8	8	8	3	3	3	3	3
Depreciation	125	125	123	113	91	84	82	67	51	44	39	41	46	38
Profit before tax	292	155	-85	-176	22	51	-48	-58	2548	97	137	77	212	146
Tax %	14	11	10	15	-50	33	25	-59	0	-12	21	3	20	22
Net Profit	253	138	-94	-202	33	34	-60	-24	2545	109	108	75	169	113
Net Profit Growth %	83.3%	246.8%	53.5%	-712.1%	-2.9%	156.7%	-150%	-100.9%	2234.9%	0.9%	44%	-55.6%	49.6%	-
EPS in Rs	35.91	19.53	-13.32	-28.72	4.7	4.87	-8.55	-3.38	361.82	11.96	11.9	8.31	18.68	12.52
Dividend Payout %	0	0	0	-14	85	82	-47	-118	1	25	17	24	43	36

Cash Flows

	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013
Cash from Operating Activity	4	-7	14	-85	-260	33	20	-328	-112	68	112	78	87	171
Cash from Investing Activity	192	-242	63	241	100	-66	-36	-286	1648	-132	-85	-52	36	-118
Cash from Financing Activity	2	184	-106	-81	191	-121	-62	-2	-881	59	-33	-51	-95	-51
Net Cash Flow	198	-65	-29	75	32	-154	-78	-616	655	-4	-7	-25	28	1

Balance Sheet

	Mar 2026	Sep 2025	Mar 2025	Sep 2024	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013
Equity Capital	14	14	14	14	14	14	14	14	14	14	14	18	18	18	18	18
Reserves	2703	2421	2437	2387	2424	2421	2604	2543	2517	2606	2666	1045	936	849	798	709
Borrowings	500	502	460	300	248	314	349	119	206	200	151	98	36	22	26	27
Other Liabilities	520	619	659	610	589	444	351	436	407	323	359	359	283	264	302	318
Total Liabilities	3737	3556	3569	3311	3275	3193	3319	3112	3145	3142	3190	1521	1274	1153	1145	1073
Fixed Assets	1213	1246	1300	1153	1252	1257	990	884	870	810	578	491	403	416	419	448
CWIP	100	79	31	145	123	147	494	568	330	92	238	250	237	123	91	132
Investments	0	0	0	0	1	2	264	392	550	926	901	14	14	41	11	39
Other Assets	2425	2231	2239	2013	1898	1787	1571	1269	1395	1313	1473	766	620	574	623	454
Total Assets	3737	3556	3569	3311	3275	3193	3319	3112	3145	3142	3190	1521	1274	1153	1145	1073

Delivery

Delivery Data: UNICHEMLAB

#	Date	427 61% 687	Value (Cr)	Q/T 34	Del 34	Del 41
1	4-Sep	550	3	22	46	1
2	3-Sep	548	4	22	44	2
3	2-Sep	560	9	20	35	3
4	1-Sep	556	11	21	27	3
5	31-Aug	557	18	21	33	6
6	28-Aug	564	18	26	38	7
7	27-Aug	540	5	24	39	2
8	26-Aug	530	4	22	34	1
9	25-Aug	526	44	31	13	6
10	24-Aug	510	2	16	53	1
11	21-Aug	526	3	21	50	2
12	20-Aug	517	4	22	42	2
13	19-Aug	513	4	21	46	2
14	18-Aug	530	6	28	45	3
15	17-Aug	543	7	23	30	2
16	14-Aug	540	5	24	34	2
17	13-Aug	542	7	22	23	2
18	12-Aug	545	54	30	19	11
19	11-Aug	574	182	46	12	22
20	10-Aug	507	4	16	47	2
21	7-Aug	490	2	17	54	1
22	6-Aug	497	5	18	39	2
23	5-Aug	497	3	26	55	2
24	4-Aug	500	2	20	49	1
25	3-Aug	505	3	18	43	1
26	31-Jul	513	2	14	55	1
27	30-Jul	524	4	21	56	2
28	29-Jul	533	2	15	34	1
29	28-Jul	534	4	19	50	2
30	27-Jul	540	3	17	27	1
31	24-Jul	537	3	13	38	1
32	23-Jul	531	11	23	37	4
33	22-Jul	529	17	26	41	7
34	21-Jul	587	3	18	34	1
35	20-Jul	596	6	19	24	2
36	17-Jul	589	9	21	31	3
37	16-Jul	605	16	21	25	4
38	15-Jul	595	14	24	30	4
39	14-Jul	581	21	23	19	4
40	13-Jul	597	27	25	23	6
41	10-Jul	639	73	33	12	9
42	9-Jul	651	623	53	13	81
43	8-Jul	573	192	56	15	29
44	7-Jul	477	17	22	39	7
45	6-Jul	463	2	20	42	1
46	3-Jul	473	5	19	30	1
47	2-Jul	466	2	15	38	1
48	1-Jul	475	9	20	39	4
49	30-Jun	462	5	25	54	3
50	29-Jun	452	12	21	25	3

Daily Market Cap

Date	Total Market Cap	Change	Chg %
04-Sep	3,896c	31c	0.81
03-Sep	3,865c	25c	0.64
01-Sep	3,890c	136c	3.38
31-Aug	4,026c	337c	9.14
27-Aug	3,689c	50c	1.33
26-Aug	3,738c	151c	4.20
25-Aug	3,588c	3c	0.08
24-Aug	3,585c	76c	2.09
21-Aug	3,661c	49c	1.36
19-Aug	3,612c	109c	2.92
18-Aug	3,721c	110c	2.86
17-Aug	3,830c	7c	0.18
14-Aug	3,823c	18c	0.46
13-Aug	3,841c	18c	0.46
12-Aug	3,823c	249c	6.96
11-Aug	3,574c	3c	0.08
10-Aug	3,577c	146c	4.26
07-Aug	3,431c	92c	2.62
06-Aug	3,523c	27c	0.78
05-Aug	3,496c	31c	0.89
04-Aug	3,527c	44c	1.24
03-Aug	3,572c	54c	1.50
31-Jul	3,626c	95c	2.55
30-Jul	3,721c	30c	0.81
29-Jul	3,751c	13c	0.34
28-Jul	3,739c	64c	1.69
27-Jul	3,803c	0	0

Stock Checklist

Price is above from 52 week high low average: 67%

Stock is trading above all short term SMAs: NO

Stock is trading above all long term SMAs: YES

Stock is Consistently Improving Long Term: NO

FII purchased in last quarter: YES

Promoters are buying the stock: NO

Mutual Fund Holdings

Held by 8 fund scheme(s) across 4 fund house(s) as of Aug26 · Total value ₹625 Cr · 2 increasing / 0 decreasing · View in MF Pro →

Fund House	Schemes	Weight %	Change	Value (Cr)
HDFC Mutual Fund	2	0.61%	-0.01%	509.2
DSP Mutual Fund	2	1.59%	+0.73%	115.5
Bandhan Mutual Fund	2	0.05%	-	0
Motilal Oswal Mutual Fund	2	0.00%	-	0

Unichem Laboratories Limited

Price Chart

Price Performance

Moving Average

PIVOT LEVEL

Competitors/Peers

Shareholding Pattern (%)

Quarterly Results

Profit and Loss

Cash Flows

Balance Sheet

Delivery

Daily Market Cap

Stock Checklist

Mutual Fund Holdings

Strategy Builder

Bulk Deals

Events

News

Exchange Filings

Annual Reports

Ratings & Research Reports

Concalls

Announcements